Clinical trial
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00004205 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT00004205 |
|---|---|
| Title | Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer |
| Official title | A Phase III Study to Evaluate Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors |
| Acronym | BIG 1-98 |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Collaborators | UNICANCER Danish Breast Cancer Cooperative Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | letrozole, tamoxifen citrate |
| Enrollment | 8,028 |
| Start date | Mar 1, 1998 |
| Primary completion | Dec 1, 2008 |
| Completion | Jun 30, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 12, 2017 |
| Countries | Denmark, France, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: